---
schema_version: "secwatch.filing_event.v1"
accession: "0001832511-26-000032"
form_type: "8-K"
ticker: "PIII"
cik: "0001832511"
company_name: "P3 Health Partners Inc."
filed_at: "2026-08-10T20:03:10+00:00"
generated_at: "2026-08-10T20:04:12.058991+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# P3 Health Partners Q2 2026: Net income $15.7M vs loss, raises FY adjusted EBITDA guidance to $80-110M

## Summary
- Q2 revenue $386M, +9% YoY; net income $15.7M vs net loss $43.7M prior-year quarter.
- Adjusted EBITDA $54.4M ($173 PMPM) vs -$17.1M (-$49 PMPM) a year ago.
- At-risk membership ~105,000, down 10% YoY on intentional network/payer rationalization.
- Medical margin $97.8M ($311 PMPM); excluding payer settlements and prior-year development, $52.9M ($168 PMPM).
- Raised full-year 2026 adjusted EBITDA guidance to $80-110M; revenue guidance $1.5-1.6B.

## SEC filing metadata
- accession: 0001832511-26-000032
- form_type: 8-K
- ticker: PIII
- cik: 0001832511
- company_name: P3 Health Partners Inc.
- filed_at: 2026-08-10T20:03:10+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1832511/000183251126000032/0001832511-26-000032-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1832511/000183251126000032/piii-20260810.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001832511-26-000032
- JSON: https://secwatch.observer/filing/0001832511-26-000032.json
- Plain text: https://secwatch.observer/filing/0001832511-26-000032.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.